Abstract
Aims
Women with gestational hyperglycemia commonly experience hypertensive disorders during pregnancy. More information is needed about how hypertension develops in these patients over time. We investigated the prevalence of hypertension during and 3 years after pregnancy in Caucasian women with gestational hyperglycemia. We also investigated metabolic syndrome presence, glucose tolerance status, insulin sensitivity and insulin secretion levels in the follow-up period.
Methods
In a prospective longitudinal study with a 3-year follow-up, we assessed hypertension status and clinical-related characteristics of 103 consecutive women with gestational hyperglycemia sub-grouped according to their hypertensive status during and after pregnancy.
Results
Overall, 29 (28.1%) women had hypertension during pregnancy (24 gestational hypertension; 4 chronic hypertension; 1 preeclampsia). At follow-up 16 (15.5%) women were diagnosed as having hypertension (11 with hypertension in pregnancy; 5 with a normotensive pregnancy). Women with hypertension after pregnancy had higher BMI, metabolic syndrome rate and worse insulin resistance indexes than normotensive women. Weight increase at follow-up (OR 1.17, 95% CI 1.00–1.35) and hypertension in pregnancy (OR 6.72, 95% CI 1.17–38.64) were associated with hypertension after pregnancy.
Conclusions
Women with gestational hyperglycemia should undergo regular monitoring during and after pregnancy to detect metabolic and clinical impairments and to prevent cardiovascular harm.
Similar content being viewed by others
References
McIntyre HD, Chang AM, Callaway LK, Cowley DM, Dyer AR, Radaelli T et al (2010) Hormonal and metabolic factors associated with variations in insulin sensitivity in human pregnancy. Diabetes Care 33:356–360
Duvekot JJ, Cheriex EC, Pieters FAA, Menheere PPCA, Peeters LLH (1993) Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol 169:1382–1392
Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J (2003) Gestational diabetes and insulin-resistance: role in short- and long-term implications for mother and fetus. J Nutr 133(5 Suppl 2):1674S–1683S
Colatrella A, Loguercio V, Mattei L, Trappolini M, Festa C, Stoppo M et al (2010) Hypertension in diabetic pregnancy: impact and long-term outlook. Best Pract Res Clin Endocrinol Metab 24:635–651
Peticca P, Keely EJ, Walker MC, Yang Q, Bottomley J (2009) Pregnancy outcomes in diabetes subtypes: how do they compare? A province-based study of Ontario, 2005–2006. J Obstet Gynaecol Can 31:487–496
Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373:1773–1779
Akinci B, Celtik A, Yener S, Yesil S (2010) Prediction of developing metabolic syndrome after gestational diabetes mellitus. Fertil Steril 93:1248–1254
Madarász E, Tamás G, Tabák AG, Kerényi Z (2009) Carbohydrate metabolism and cardiovascular risk factors 4 years after a pregnancy complicated by gestational diabetes. Diabetes Res Clin Pract 85:197–202
Metzger BE, Coustan DR (1998) Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. Diabetes Care 20(Suppl 2):B161–B167
Higgins JR, de Swiet M (2001) Blood-pressure measurement and classification in pregnancy. Lancet 357:131–135
Sherwin RS, Anderson RM, Buse JB, Chin MH, Eddy D, Fradkin J et al (2003) The prevention or delay of type 2 diabetes. Diabetes Care 26(Suppl 1):S62–S69
Società Italiana di Diabetologia (SID)-Associazione Medici Diabetologi (AMD) (2007) Standard italiani per la cura del Diabete Mellito 2007. http://www.aemmedi.it/files/Linee-guida_Raccomandazioni/2007/2007-cura-diabete-mellito.pdf
American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35(Suppl 1):S64–S71
Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart Association, National Heart, Lung, and Blood Institute (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433–438
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470
Utzschneider KM, Prigeon RL, Faulenbach MV, Tong J, Carr DB, Boyko EJ et al (2009) Oral Disposition Index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 32:335–341
Stumvoll M, Mitralou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T et al (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295–301
(2009). https://ebiblio.istat.it/digibib/AnnuarioStatisticoItaliano/RAV0040597ASI2009.pdf
Mahendru AA, Everett TR, Wilkinson IB, Lees CC, McEniery CM (2014) A longitudinal study of maternal cardiovascular function from preconception to the postpartum period. J Hypertens 32:849–856
Davis CL, Gutt M, Llabre MM, Marks JB, O’Sullivan MJ, Potter JE et al (1999) History of gestational diabetes, insulin resistance and coronary risk. J Diabetes Complicat 13:216–223
Ferrannini E, Cushman WC (2012) Diabetes and hypertension: the bad companions. Lancet 380:601–610
Pirkola J, Pouta A, Bloigu A, Hartikainen AL, Laitinen J, Järvelin MR et al (2010) Prepregnancy overweight and gestational diabetes as determinants of subsequent diabetes and hypertension after 20-year follow-up. J Clin Endocrinol Metab 95:772–778
Bianchi C, Miccoli R, Bonadonna RC, Giorgino F, Frontoni S, Faloia E et al (2011) Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. Nutr Metab Cardiovasc Dis 21:699–705
O’Driscoll G (1997) Simvastatin and HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95:1126–1131
Desouza CV (2013) Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes? J Diabetes Complicat 27:519–525
Luo P, Yan M, Frohlich ED, Mehta JL, Hu C (2011) Novel concepts in the genesis of hypertension: role of LOX-1. Cardiovasc Drugs Ther 25:441–449
Bo S, Valpreda S, Menato G, Bardelli C, Botto C, Gambino R et al (2007) Should we consider gestational diabetes a vascular risk factor? Atherosclerosis 194:e72–e79
Yogev Y, Chen R, Hod M, Coustan DR, Oats JN, McIntyre DH et al (2010) Hyperglycemia and adverse pregnancy outcome (HAPO) study: preeclampsia. Am J Obstet Gynecol 202:255.e1–7
Colatrella A, Braucci S, Festa C, Bianchi P, Fallucca F, Mattei L et al (2009) Hypertensive disorders in normal/over-weight and obese type 2 diabetic pregnant women. Exp Clin Endocrinol Diabetes 117:373–377
Napoli A, Sabbatini A, Di Biase N, Marceca M, Colatrella A, Fallucca F (2003) Twenty-four-hour blood pressure monitoring in normoalbuminuric normotensive type 1 diabetic women during pregnancy. J Diabetes Complicat 17:292–296
Jensen DM, Damm P, Ovesen P, Mølsted-Pedersen L, Beck-Nielsen H, Westergaard JG et al (2010) Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: results from a nationwide Danish study. Diabetes Care 33:90–94
Tobias DK, Hu FB, Forman JP, Chavarro J, Zhang C (2011) Increased risk of hypertension after gestational diabetes mellitus: findings from a large prospective cohort study. Diabetes Care 34:1582–1584
Tovar A, Chasan-Taber L, Eggleston E, Oken E (2011) Postpartum screening for diabetes among women with a history of gestational diabetes mellitus. Prev Chronic Dis 8:A124
Korpi-Hyövälti E, Laaksonen DE, Schwab U, Heinonen S, Niskanen L (2012) How can we increase postpartum glucose screening in women at high risk for gestational diabetes mellitus? Int J Endocrinol 2012:519267
La Marca A, Grisendi V, Dondi G, Sighinolfi G, Cianci A (2015) The menstrual cycle regularization following d-chiro-inositol treatment in PCOS women: a retrospective study. Gynecol Endocrinol 31(1):52–56
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Festa, C., Mattei, L., Bitterman, O. et al. Hypertensive disorders during pregnancy and 3 years after delivery in women with gestational hyperglycemia. J Endocrinol Invest 41, 1075–1082 (2018). https://doi.org/10.1007/s40618-018-0833-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-018-0833-0